Domestic medical silicone gel breast forms are gaining traction, but some manufacturers cut corners by diluting with ordinary silicone oil. The result? A persistent tacky surface post-cure.
Root cause: low-molecular cyclic siloxanes (D3–D6) in non-medical silicones migrate outward over time. Though invisible, these compounds create a greasy film, compromise aesthetics, and raise biocompatibility concerns. D4 and D5 are already flagged under EU REACH; D3 carries reproductive toxicity warnings.
True medical-grade gels require D3–D6 content below 100 ppm (ideally <10 ppm), ISO 10993-compliant toxicology data, and production under controlled GMP conditions. “Using recycled or industrial oil might save costs today,” warns a biomaterials engineer, “but it risks patient trust tomorrow.”
